CYP2A6 c.1161+30G>C

Variant ID: 19-41351169-C-G

NM_000762.5(CYP2A6):c.1161+30G>C

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid.

Southern African Journal Of Hiv Medicine
Decloedt, Eric H EH; Sinxadi, Phumla Z PZ; Wiesner, Lubbe L; Joska, John A JA; Haas, David W DW; Maartens, Gary G
Publication Date: 2021

Variant appearance in text: rs4803380
PubMed Link: 34007475
Variant Present in the following documents:
  • Main text
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs4803380
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.

Antimicrobial Agents And Chemotherapy
Robarge, Jason D JD; Metzger, Ingrid F IF; Lu, Jessica J; Thong, Nancy N; Skaar, Todd C TC; Desta, Zeruesenay Z; Bies, Robert R RR
Publication Date: 2017-01

Variant appearance in text: rs4803380
PubMed Link: 27799204
Variant Present in the following documents:
  • Main text
View BVdb publication page